| 000 | 01381 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516175510.0 | ||
| 264 | 0 | _c20140620 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1875-8630 | ||
| 024 | 7 |
_a10.1155/2013/935943 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Li | |
| 245 | 0 | 0 |
_aSerum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma. _h[electronic resource] |
| 260 |
_bDisease markers _c2013 |
||
| 300 |
_a317-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCyclins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aYue, Wentao | |
| 700 | 1 | _aTeng, Yu | |
| 700 | 1 | _aZhang, Lina | |
| 700 | 1 | _aGu, Meng | |
| 700 | 1 | _aWang, Yue | |
| 773 | 0 |
_tDisease markers _gvol. 35 _gno. 5 _gp. 317-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2013/935943 _zAvailable from publisher's website |
| 999 |
_c23208992 _d23208992 |
||